Major Histocompatibility Complex: Clinical Significance of anti-HLA Antibodies: Part II


Back to Unit

Author: Adriana Zeevi, MD

1. Describe a virtual crossmatch and its role in determining acceptable donors.
2. Understand the different types and timing of antibody mediated rejection.
3. Understand the clinical application of the presence of donor specific antibodies (DSA) in sensitized patients.

Key:

Complete
Failed
Available
Locked
Video
Open to view video.
Open to view video.
References
Open to download resource.
Open to download resource.
Quiz
4 Questions  |  Unlimited attempts  |  0/4 points to pass
4 Questions  |  Unlimited attempts  |  0/4 points to pass
Curriculum Feedback Survey
5 Questions
5 Questions We value your opinion. Please take a moment to provide your feedback.
Curriculum Completion
Live Viewing: 1.00 Completion credit and no certificate available
Live Viewing: 1.00 Completion credit and no certificate available